What is the ticker symbol for Theseus Pharmaceuticals?

Theseus Pharmaceuticals trades under the ticker THRX on NASDAQ.

What sector does Theseus Pharmaceuticals operate in?

Theseus Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze THRX in a portfolio?

PortView shows THRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Theseus Pharmaceuticals (THRX) Stock Analysis

NASDAQHealthcareBiotechnology

$4.07+0.12%

1-year price historyRange $2.12 – $11.82

52-week range$4.07

$2.05$12.37

What Theseus Pharmaceuticals does

Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.

Key metrics

Market cap

$181.50M

P/E (TTM)

-3.03

EPS (TTM)

$-1.34

Beta

3.98

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$3.95

200-day avg

$5.00

52-week high

$12.37

52-week low

$2.05

CEO

Iain D. Dukes DPHIL,

ETFs linked to THRX

Broad-market and Healthcare sector ETFs an investor holding Theseus Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how THRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze THRX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Theseus Pharmaceuticals?: Theseus Pharmaceuticals trades under the ticker THRX on NASDAQ.
Which exchange is THRX listed on?: THRX is listed on NASDAQ.
What sector does Theseus Pharmaceuticals operate in?: Theseus Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze THRX in a portfolio?: PortView shows THRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.